Markers of Antioxidant Defense in Patients with Type 2 Diabetes

Table 3

Comparison of selected clinical and biochemical parameters in patients with and without chronic diabetes complications.

Parameter	Complications ()	No complications ()
Age [years]	60.9 ± 9.0	57.9 ± 13.9	0.009
BMI	30.92 ± 5.24	32.22 ± 6.22	0.315
Diabetes duration [years]	10 (7–16)	5 (1–9)	<0.001
Mean daily glucose [mmol/L]	6.3 ± 1.0	6.3 ± 1.1	0.651
HbA1c [mmol/mol]	69.4 (58.5–74.9)	77.1 (51.9–92.4)	0.372
[%]	8.5 (7.5–9.0)	9.2 (6.9–10.6)
Creatinine [mol/L]	66.4 (59.4–76.0)	67.8 (56.1–83.0)	0.891
FRAP [mmol/L]	1.00 ± 0.22	0.94 ± 0.20	0.512
GPxplasma [U/L]	234.5 (89.2–60.5)	236.9 (98.4–59.3)	0.950
GPxhemolysate [U/gHg]	43.1 ± 22.0	44.6 ± 21.1	0.819
GRplasma [U/L]	73.1 ± 18.2	75.5 ± 24.5	0.063
GRhemolysate [U/gHg]	33.1 (27.1–38.6)	32.8 (26.7–37.9)	0.969
Glutatione [μmol/L]	0.88 (0.53–1.18)	0.94 (0.71–1.21)	0.402
Uric acid [μmol/L]	381.0 ± 131.0	345.2 ± 71.4	0.170
GGT [U/L]	22.5 (12–38)	25.5 (10.0–34.0)	0.711
CRP [mg/L]	1.7 (0.5–4.4)	2.7 (1.1–10.0)	0.117

Data are expressed as mean ± SD, median and interquartile range, or percentage of frequency [%], as appropriate.